Loading provider…
Loading provider…
Medical Oncology Physician in Fort Myers, FL
NPI: 1316920259Primary Practice Location
GULF COAST MEDICAL CENTER LEE HEALTH
13681 Doctors Way, Fort Myers, FL
Primary Employer
Florida Cancer Specialists & Research Institute - Cape Coral Cay West
flcancer.com
HQ Phone
Get DO Michael's Phone NumberMobile
Get DO Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License

NJ State License
1986 - 2027

FL State License
1990 - 2026

PA State License
1989 - 1989
Oklahoma State University College Of Osteopathic Medicine
medicine.okstate.edu
Medical School
Until 1985
Jefferson Stratford Hospital
Fellowship • 1988 - 1990
1988 - 1990
RowanSOM/Jefferson Health/Virtua Our Lady of Lourdes Hospital
Residency • Internal Medicine
1986 - 1988
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 822 | 2,294 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 791 | 2,016 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 440 | 942 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 218 | 579 |
| 5 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 214 | 768 |
A randomized, phase 2 study of R-CHOP plus enzastaurin vs R-CHOP in patients with intermediate- or high-risk diffuse large B-cell lymphoma.
Authors: John Hainsworth, Edward Arrowsmith, Luis Fayad
Publication Date: 2015-05-10
Authors: Lee Schwartzberg, Maen Hussein, Edward Garon, Benjamin Creelan
Journal: J Thorac Oncol
Publication Date: 2019-05-20
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Prexasertib
Lead Sponsor: Eli Lilly and Company
Collaborators: AstraZeneca
Intervention / Treatment: DRUG: Osimertinib, DRUG: Ramucirumab, DRUG: Necitumumab
Lead Sponsor: Eli Lilly and Company
Collaborators: SCRI Development Innovations, LLC
Intervention / Treatment: DRUG: LY3023414, DRUG: Necitumumab